tiprankstipranks
Mereo Biopharma (MREO)
NASDAQ:MREO
US Market
MREO
Mereo Biopharma Group Plc
RESEARCH TOOLSreports
Want to see MREO full AI Analyst Report?

Mereo Biopharma Group Plc (MREO) Ratios

868 Followers

Mereo Biopharma Group Plc Ratios

MREO's free cash flow for Q1 2026 was $0.00. For the 2026 fiscal year, MREO's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 6.48 10.46 5.40 6.72 3.09
Quick Ratio
 6.48 10.46 5.40 6.72 3.09
Cash Ratio
 5.86 9.53 5.04 6.05 2.80
Solvency Ratio
 -5.25 -8.14 -2.73 -1.78 -1.58
Operating Cash Flow Ratio
 -4.36 -7.20 -2.37 -2.23 -2.00
Short-Term Operating Cash Flow Coverage
 0.00 -153.32 -5.93 0.00 -3.66
Net Current Asset Value
$ 33.47M$ 40.02M$ 59.34M$ 47.80M$ 49.19M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 <0.01 0.08 0.09 0.20
Debt-to-Equity Ratio
 0.00 <0.01 0.11 0.12 0.30
Debt-to-Capital Ratio
 0.00 <0.01 0.10 0.11 0.23
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.08 0.00
Financial Leverage Ratio
 1.19 1.12 1.25 1.32 1.51
Debt Service Coverage Ratio
 -714.87 -88.56 -5.91 -8.86 -2.26
Interest Coverage Ratio
 -686.75 -150.03 -34.56 -9.86 -15.97
Debt to Market Cap
 0.00 <0.01 0.01 0.01 0.15
Interest Debt Per Share
 <0.01 <0.01 0.05 0.07 0.16
Net Debt to EBITDA
 0.92 1.01 1.55 1.98 1.32
Profitability Margins
Gross Profit Margin
12.50%73.40%0.00%74.26%0.00%
EBIT Margin
-8108.06%-8324.60%0.00%-271.17%0.00%
EBITDA Margin
-7858.36%-8094.80%0.00%-260.56%0.00%
Operating Profit Margin
-7531.06%-7651.40%0.00%-284.16%0.00%
Pretax Profit Margin
-7158.72%-8375.60%0.00%-299.98%0.00%
Net Profit Margin
-7139.75%-8375.60%0.00%-294.66%0.00%
Continuous Operations Profit Margin
-7139.75%-8375.60%0.00%-294.66%0.00%
Net Income Per EBT
99.74%100.00%100.00%98.23%94.74%
EBT Per EBIT
95.06%109.46%91.32%105.57%82.84%
Return on Assets (ROA)
-87.90%-91.20%-56.62%-44.31%-54.41%
Return on Equity (ROE)
-81.25%-102.35%-70.94%-58.31%-81.95%
Return on Capital Employed (ROCE)
-109.35%-91.93%-75.73%-49.84%-101.19%
Return on Invested Capital (ROIC)
-109.06%-91.49%-68.86%-48.40%-75.97%
Return on Tangible Assets
-88.73%-92.24%-57.10%-45.05%-54.41%
Earnings Yield
-81.81%-63.04%-8.35%-9.67%-46.55%
Efficiency Ratios
Receivables Turnover
 0.00 0.33 0.00 2.68 0.00
Payables Turnover
 0.14 0.10 0.00 1.10 -0.07
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 2.51 1.31 0.00 6.06 0.00
Asset Turnover
 0.01 0.01 0.00 0.15 0.00
Working Capital Turnover Ratio
 0.01 <0.01 0.00 0.19 0.00
Cash Conversion Cycle
 -2.69K -2.57K 0.00 -196.45 4.95K
Days of Sales Outstanding
 0.00 1.09K 0.00 136.22 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 2.69K 3.66K 0.00 332.67 -4.95K
Operating Cycle
 0.00 1.09K 0.00 136.22 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.17 -0.19 -0.22 -0.16 -0.40
Free Cash Flow Per Share
 -0.17 -0.19 -0.23 -0.16 -0.40
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.02 1.02 1.00
Dividend Paid and CapEx Coverage Ratio
 -17.72K -1.55K -46.97 -50.43 -3.76K
Capital Expenditure Coverage Ratio
 -17.72K -1.55K -46.97 -50.43 -3.76K
Operating Cash Flow Coverage Ratio
 0.00 -153.32 -5.11 -3.55 -3.18
Operating Cash Flow to Sales Ratio
 -53.91 -61.94 0.00 -2.11 0.00
Free Cash Flow Yield
-62.06%-46.65%-6.48%-7.07%-53.97%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.22 -1.59 -11.97 -10.34 -2.15
Price-to-Sales (P/S) Ratio
 86.86 132.86 0.00 30.47 0.00
Price-to-Book (P/B) Ratio
 1.28 1.62 8.49 6.03 1.76
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.61 -2.14 -15.44 -14.14 -1.85
Price-to-Operating Cash Flow Ratio
 -1.62 -2.14 -15.77 -14.42 -1.85
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 0.14 0.12 0.28 <0.01
Price-to-Fair Value
 1.28 1.62 8.49 6.03 1.76
Enterprise Value Multiple
 -0.18 -0.63 -11.14 -9.72 -0.94
Enterprise Value
 7.21M 25.64M 454.36M 253.20M 37.67M
EV to EBITDA
 -0.18 -0.63 -11.14 -9.72 -0.94
EV to Sales
 14.42 51.28 0.00 25.32 0.00
EV to Free Cash Flow
 -0.27 -0.83 -13.55 -11.75 -0.77
EV to Operating Cash Flow
 -0.27 -0.83 -13.84 -11.98 -0.77
Tangible Book Value Per Share
 0.21 0.25 0.41 0.37 0.43
Shareholders’ Equity Per Share
 0.21 0.26 0.41 0.38 0.43
Tax and Other Ratios
Effective Tax Rate
 <0.01 0.00 0.00 0.02 0.05
Revenue Per Share
 <0.01 <0.01 0.00 0.08 0.00
Net Income Per Share
 -0.22 -0.26 -0.29 -0.22 -0.35
Tax Burden
 1.00 1.00 1.00 0.98 0.95
Interest Burden
 0.88 1.01 1.03 1.11 1.09
Research & Development to Revenue
 36.26 35.53 0.00 1.74 0.00
SG&A to Revenue
 39.51 46.02 0.00 1.84 0.00
Stock-Based Compensation to Revenue
 10.43 15.20 0.00 0.49 0.00
Income Quality
 0.75 0.74 0.76 0.72 1.16
Currency in USD